{"nct_id":"NCT04888585","title":"Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)","status":"TERMINATED","status_verified_date":"2024-09","start_date":"2021-06-23","start_date_type":"ACTUAL","primary_completion_date":"2022-08-25","primary_completion_date_type":"ACTUAL","completion_date":"2023-08-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}